Test Price
16,000 AED✅ Home Collection Available
Oncomine Comprehensive Panel + Tumor Mutation Burden (TMB) + Microsatellite Instability (MSI) + PD-L1 (IHC) in UAE | 16000 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Archival tissue specimen retrieval via secure medical courier; blood sample collected on-site at DNA Labs UAE or partner clinics.
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by DHA-licensed specialists.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced tumor profiling solution simultaneously interrogates hundreds of cancer-related genes by Next-Generation Sequencing (NGS) and Immunohistochemistry (IHC), delivering a complete molecular portrait to guide targeted therapy, immunotherapy eligibility, and hereditary risk assessment.
| Feature | Our Test (Oncomine Comprehensive) | Closest Alternative (Single-Gene Testing) |
|---|---|---|
| Profile Depth | >500 genes (full coding regions) by NGS, plus TMB, MSI, PD-L1 | 1–10 genes, limited mutation types |
| Methodological Precision | NGS + Sanger confirmation + IHC; validated per FDA/CE-IVD standards | Sanger sequencing or PCR; no immunotherapy markers |
| Turnaround Time | 2–3 weeks | 5–7 days (incomplete oncogenic picture) |
Physician Insight & Safety Protocols
"This comprehensive panel provides a detailed molecular portrait that is invaluable for guiding targeted and immunotherapeutic strategies. However, it is crucial to interpret these results in the context of the patient's full clinical history and radiological findings. The data are not a standalone diagnosis but a powerful tool for precision oncology." – Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA ID 61713011
Clinical Advisory & Preparation
A valid prescription from a DHA-licensed physician is required. Patients must provide sufficient tumor tissue (≥10% neoplastic nuclei) for accurate analysis. Do not discontinue any prescribed medications without consulting your treating physician.
Safety Exclusion Criteria & Emergency Red Flags
- This test requires a valid prescription from a DHA-licensed physician. Exceptions only for documented surgical clearance, pregnancy-related protocols, or travel vaccination programs as per UAE law.
- Tumor tissue must have ≥10% neoplastic nuclei; insufficient material will delay results.
- If you experience severe unprovoked bleeding, rapid weight loss >5% in one month, or acute dyspnea, seek emergency medical care immediately.
Patient FAQ & Clinical Guidance
1. What exactly does this panel detect, and how does it influence my treatment?
A: This comprehensive genomic panel identifies key mutations, tumor mutational burden, microsatellite instability, and PD-L1 expression to guide precise cancer therapy. The integrated biomarkers reveal eligibility for FDA/EMA-approved targeted drugs and immunotherapies, while also flagging potential hereditary cancer syndromes.
2. Why do I need to provide both tumor tissue and a blood sample?
A: Tumor tissue is analyzed for somatic mutations, while blood serves as a germline control to distinguish inherited mutations from acquired ones. This dual-sample approach ensures that variants reported as "somatic" are truly tumor-specific, preventing false attribution of germline findings to the cancer.
3. How reliable are the results, and will my UAE health insurance cover the cost?
A: Our ISO-certified laboratory delivers 99.9% analytical sensitivity; most UAE insurers reimburse this advanced when medically necessary. We provide direct billing verification; simply send your insurance card via WhatsApp to +971 54 548 8731, and we will confirm coverage within one business day.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data are encrypted and handled under strict confidentiality protocols. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Oncomine Comprehensive Panel + TMB + MSI + PD-L1 (IHC) |
| Price (AED) | 16,000 |
| Turnaround Time | 14–21 business days |
| Sample Type / Matrix | Tumor tissue (formalin-fixed paraffin-embedded block or unstained slides) and peripheral whole blood |
| Methodology Used | Next-Generation Sequencing (NGS) and Immunohistochemistry (IHC) |
| ICD-10-CM Code | Z15.09, Z15.01, Z15.02 |
| LOINC Code | 101661-5 |
| DHA Facility License & Address | DNA Labs UAE, DHA License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians